Ofer subsidiary OG Tech Ventures has bought the Santander-backed hospitality payment technology provider for an undisclosed amount.
Author: Robert Lavine
JW Therapeutics jumps on $90m
Founding investors WuXi AppTec and Juno Therapeutics returned for a series A round that will support development of JW’s cell-based therapy pipeline.
Hua Medicine to hunt down $400m in IPO
The diabetes treatment developer will target at least $400m from a Hong Kong offering that will allow WuXi PharmaTech to exit.
Tencent hurls $462m to Huya
Hot on the heels of its $630m investment in Douyu, Tencent has agreed another huge funding deal with a game-focused livestreaming platform.
The Athletic works out $20m in funding
BDMI, Chernin Group and the WPP-backed Courtside Ventures were among the investors as the sports media platform looks to double its headcount.
Aisin and Fenox assemble $50m automotive fund
Auto parts manufacturer Aisin Group will be a limited partner in the autotech fund, which will be managed by Fenox Venture Capital.
BBVA attends to Atom in $207m round
BBVA invested $119m to increase its stake in the mobile bank to 39%, with the round’s proceeds to support technology development and growth.
Magic Leap surpasses $960m in series D
Public Investment Fund provided $400m as the AR technology developer took a round backed by Alibaba, Google and Grupo Globo to $963m.
Douyu gets to next stage with $630m Tencent investment
Tencent has been an investor in the game streaming platform since early 2016, the same year the companies formed a strategic partnership.
Unum unveils $86m IPO filing
The immuno-oncology therapy developer, which is backed by Novo, Sanofi, EMS and Seattle Genetics, has raised $77m in venture funding.
BugCrowd sources $26m in series C
Salesforce Ventures returned for a round that increased the crowdsourced cybersecurity platform’s overall funding to $50m.
Capital G gets on UiPath for $153m round
US-based task automation software provider UiPath secured $153m yesterday in a series B round featuring CapitalG, a subsidiary of internet and technology group Alphabet, at a $1.1bn valuation. The round was led by Accel and included fellow venture capital firms Kleiner Perkins Caufield & Byers, Credo Ventures and Earlybird, the latter investing through its Digital… Continue reading Capital G gets on UiPath for $153m round
PharmEasy takes care in $30m series C
Manipal Education and Medical Group has participated in a round that took the total raised by the healthcare product and access platform to $53m.
Homology to hone $100m IPO
Rare disease therapy developer Homology Medicines has raised approximately $130m in VC funding from investors including Novartis.